Charles Schwab’s Asensus Surgical, Inc. ASXC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-88,725
| Closed | -$29.5K | – | 3636 |
|
|
2024
Q2 | $29.5K | Hold |
88,725
| – | – | ﹤0.01% | 3565 |
|
|
2024
Q1 | $20.4K | Hold |
88,725
| – | – | ﹤0.01% | 3436 |
|
|
2023
Q4 | $28.3K | Hold |
88,725
| – | – | ﹤0.01% | 3456 |
|
|
2023
Q3 | $24K | Hold |
88,725
| – | – | ﹤0.01% | 3493 |
|
|
2023
Q2 | $44.8K | Hold |
88,725
| – | – | ﹤0.01% | 3434 |
|
|
2023
Q1 | $58.4K | Sell |
88,725
-51,221
| -37% | -$34.7K | ﹤0.01% | 3325 |
|
|
2022
Q4 | $48.6K | Hold |
139,946
| – | – | ﹤0.01% | 3365 |
|
|
2022
Q3 | $63K | Buy |
+139,946
| New | +$73K | ﹤0.01% | 3280 |
|
|
2022
Q2 | – | Sell |
-599,280
| Closed | -$376K | – | 3672 |
|
|
2022
Q1 | $376K | Hold |
599,280
| – | – | ﹤0.01% | 3162 |
|
|
2021
Q4 | $666K | Buy |
599,280
+17,713
| +3% | +$27.4K | ﹤0.01% | 3059 |
|
|
2021
Q3 | $1.08M | Sell |
581,567
-2,700
| -0.5% | -$6.06K | ﹤0.01% | 2851 |
|
|
2021
Q2 | $1.85M | Buy |
584,267
+533,025
| +1,040% | +$1.33M | ﹤0.01% | 2744 |
|
|
2021
Q1 | $167K | Buy |
+51,242
| New | +$186K | ﹤0.01% | 3338 |
|
|
2020
Q3 | – | Sell |
-142,343
| Closed | -$78K | – | 3369 |
|
|
2020
Q2 | $78K | Sell |
142,343
-17,370
| -11% | -$8.38K | ﹤0.01% | 3249 |
|
|
2020
Q1 | $57K | Buy |
159,713
+58,085
| +57% | +$60.6K | ﹤0.01% | 3146 |
|
|
2019
Q4 | $150K | Buy |
101,628
+15,697
| +18% | +$54.5K | ﹤0.01% | 3072 |
|
|
2019
Q3 | $693K | Buy |
85,931
+1,832
| +2% | +$24.9K | ﹤0.01% | 2675 |
|
|
2019
Q2 | $1.49M | Buy |
84,099
+4,646
| +6% | +$102K | ﹤0.01% | 2458 |
|
|
2019
Q1 | $2.46M | Buy |
79,453
+4,637
| +6% | +$155K | ﹤0.01% | 2293 |
|
|
2018
Q4 | $2.2M | Buy |
74,816
+1,028
| +1% | +$46.7K | ﹤0.01% | 2303 |
|
|
2018
Q3 | $5.56M | Buy |
73,788
+48,973
| +197% | +$3.31M | ﹤0.01% | 1988 |
|
|
2018
Q2 | $1.41M | Buy |
+24,815
| New | +$904K | ﹤0.01% | 2480 |
|
|
2017
Q2 | – | Sell |
-11,054
| Closed | -$174K | – | 3146 |
|
|
2017
Q1 | $174K | Hold |
11,054
| – | – | ﹤0.01% | 2952 |
|
|
2016
Q4 | $187K | Hold |
11,054
| – | – | ﹤0.01% | 2974 |
|
|
2016
Q3 | $243K | Hold |
11,054
| – | – | ﹤0.01% | 2858 |
|
|
2016
Q2 | $176K | Buy |
11,054
+6,969
| +171% | +$219K | ﹤0.01% | 2982 |
|
|
2016
Q1 | $226K | Sell |
4,085
-3,353
| -45% | -$144K | ﹤0.01% | 2859 |
|
|
2015
Q4 | $240K | Buy |
7,438
+4,200
| +130% | +$135K | ﹤0.01% | 2925 |
|
|
2015
Q3 | $96K | Hold |
3,238
| – | – | ﹤0.01% | 3037 |
|
|
2015
Q2 | $127K | Hold |
3,238
| – | – | ﹤0.01% | 3037 |
|
|
2015
Q1 | $124K | Hold |
3,238
| – | – | ﹤0.01% | 3013 |
|
|
2014
Q4 | $123K | Hold |
3,238
| – | – | ﹤0.01% | 3048 |
|
|
2014
Q3 | $184K | Hold |
3,238
| – | – | ﹤0.01% | 2973 |
|
|
2014
Q2 | $213K | Buy |
+3,238
| New | +$187K | ﹤0.01% | 2978 |
|
Other funds holding ASXC
Charles Schwab's ASXC Position: Q3 2024 in Review
Charles Schwab sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 88,725 shares — an estimated $29.5K sold.
Charles Schwab first reported a position in ASXC in Q2 2014 and held it in 34 quarters. The position peaked at $5.56M in Q3 2018. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.
- Charles Schwab reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
- Charles Schwab sold 88,725 Asensus Surgical, Inc. shares in Q3 2024, an estimated $29.5K.
- Charles Schwab first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 34 quarters.
- Charles Schwab's Asensus Surgical, Inc. position peaked at $5.56M in Q3 2018.
- 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.
Based on Charles Schwab's 13F filing for Q3 2024, filed 12 Nov 2024.